Psychiatry and Neurology, Neurology · Miami, FL
NPI
1851547764
Since 2008
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1400 NW 12th Ave
Miami, FL, 33136
Phone (305) 243-3100
Groups this clinician bills Medicare through
Medicare paid, 2024
$28K
275 services
Medicare patients, 2024
151
Average age 62
Drug cost, 2024
$1.2M
2,240 prescriptions
Company payments, 2025
$619
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ramses Ribot was code 99214 (office e&m - established), 64 times for 44 patients. In total Ramses Ribot billed 275 services in 25 codes, and Medicare paid $28K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-07-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 64 | 44 | $86.21 | $5,517 |
| 95720 Neurologic | Facility | 39 | 17 | $172.37 | $6,722 |
| 95819 Neurologic | Facility | 25 | 24 | $43.98 | $1,100 |
| 99214 Office E&M - Established | Facility | 23 | 18 | $69.44 | $1,597 |
By year: 2022 $51K for 424 services; 2023 $40K for 343 services; 2024 $28K for 275 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ramses Ribot prescribed most often to Medicare patients was Clobazam, with 236 prescriptions and refills. In total Ramses Ribot wrote 2,240 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Clobazam Generic | 236 | 260 | 36 | $22K |
| Lamotrigine Generic | 220 | 411 | 51 | $3,842 |
| Levetiracetam Generic | 205 | 361 | 43 | $8,682 |
| Lacosamide Generic | 168 | 189 | 28 | $23K |
| Clonazepam Generic | 151 | 151 | 24 | $1,475 |
| Divalproex Sodium Er Divalproex Sodium | 138 | 274 | 29 | $9,791 |
| Oxcarbazepine Generic | 102 | 158 | 20 | $7,290 |
| Phenobarbital Generic | 68 | 80 | Under 11 | $899 |
| Pregabalin Generic | 55 | 55 | Under 11 | $844 |
| Epidiolex Cannabidiol (Cbd) | 54 | 54 | Under 11 | $369K |
| Fycompa Perampanel | 52 | 52 | Under 11 | $82K |
| Zonisamide Generic | 51 | 79 | Under 11 | $1,631 |
| Gabapentin Generic | 46 | 70 | Under 11 | $622 |
| Lamictal Lamotrigine | 45 | 71 | Under 11 | $66K |
| Valproic Acid Valproic Acid (As Sodium Salt) | 42 | 42 | Under 11 | $2,144 |
Brand drugs: 452 claims; generic drugs: 1,720 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ramses Ribot $619 ($619 in general payments such as food, travel and fees) from 4 companies. The largest payer was Jazz Pharmaceuticals Inc. with $203.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.